CompaniesDeuterOncology
DeuterOncology logo

DeuterOncology

active
Liège, Belgium
Founded 2020
Website
About

Brain penetrant deuterated MET kinase and RAS pathway inhibitor

Areas of Focus

Categories

Small Molecule Pharmaceutical
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

25

By Phase

PHASE1: 1

By Status

ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
Today
NCT05752552
Hover over trial bars to see details

Recent Trials

NCT05752552Lead Sponsor
Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours
PHASE1Active, not recruiting
25 participants
Started: Dec 20, 2022 · Completed: Dec 31, 2026
Locations (1)
Headquarters
Liège, Belgium
Map

Loading map...